vs
AYTU BIOPHARMA, INC（AYTU）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是AYTU BIOPHARMA, INC的1.7倍（$25.9M vs $15.2M），REDWOOD TRUST INC净利率更高（77.2% vs -69.8%，领先147.0%），REDWOOD TRUST INC同比增速更快（-6.1% vs -6.5%），过去两年AYTU BIOPHARMA, INC的营收复合增速更高（4.0% vs -41.0%）
AYTU生物制药是一家总部位于美国的特种制药企业，研发并商业化消费级健康产品与处方治疗药物，产品线覆盖感冒过敏用药、生殖健康解决方案及罕见儿科疾病治疗药物，服务美国本土患者与医疗服务提供者。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
AYTU vs RWT — 直观对比
营收规模更大
RWT
是对方的1.7倍
$15.2M
营收增速更快
RWT
高出0.4%
-6.5%
净利率更高
RWT
高出147.0%
-69.8%
两年增速更快
AYTU
近两年复合增速
-41.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $15.2M | $25.9M |
| 净利润 | $-10.6M | $20.0M |
| 毛利率 | 63.5% | — |
| 营业利润率 | -13.0% | — |
| 净利率 | -69.8% | 77.2% |
| 营收同比 | -6.5% | -6.1% |
| 净利润同比 | -1443.1% | 402.6% |
| 每股收益（稀释后） | $-1.05 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AYTURWT
| Q4 25 | $15.2M | $25.9M | ||
| Q3 25 | $13.9M | $15.0M | ||
| Q2 25 | $15.1M | $13.8M | ||
| Q1 25 | $18.5M | $27.9M | ||
| Q4 24 | $16.2M | $27.6M | ||
| Q3 24 | $16.6M | $25.5M | ||
| Q2 24 | $14.6M | $67.4M | ||
| Q1 24 | $14.0M | $74.5M |
净利润AYTURWT
| Q4 25 | $-10.6M | $20.0M | ||
| Q3 25 | $2.0M | $-7.7M | ||
| Q2 25 | $-19.8M | $-98.5M | ||
| Q1 25 | $4.0M | $16.1M | ||
| Q4 24 | $788.0K | $-6.6M | ||
| Q3 24 | $1.5M | $14.8M | ||
| Q2 24 | $-4.6M | $15.5M | ||
| Q1 24 | $-2.9M | $30.3M |
毛利率AYTURWT
| Q4 25 | 63.5% | — | ||
| Q3 25 | 66.1% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 69.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 72.3% | — | ||
| Q2 24 | 75.7% | — | ||
| Q1 24 | 73.9% | — |
营业利润率AYTURWT
| Q4 25 | -13.0% | — | ||
| Q3 25 | -10.8% | -9.0% | ||
| Q2 25 | -50.4% | -679.0% | ||
| Q1 25 | 13.1% | 80.2% | ||
| Q4 24 | -10.4% | -1.3% | ||
| Q3 24 | -5.6% | 86.1% | ||
| Q2 24 | -15.6% | 30.3% | ||
| Q1 24 | -11.4% | 41.3% |
净利率AYTURWT
| Q4 25 | -69.8% | 77.2% | ||
| Q3 25 | 14.1% | -51.4% | ||
| Q2 25 | -130.9% | -712.0% | ||
| Q1 25 | 21.6% | 57.8% | ||
| Q4 24 | 4.9% | -24.0% | ||
| Q3 24 | 8.9% | 58.1% | ||
| Q2 24 | -31.6% | 23.0% | ||
| Q1 24 | -20.6% | 40.6% |
每股收益（稀释后）AYTURWT
| Q4 25 | $-1.05 | $0.11 | ||
| Q3 25 | $-0.08 | $-0.08 | ||
| Q2 25 | — | $-0.76 | ||
| Q1 25 | $0.21 | $0.10 | ||
| Q4 24 | $-0.26 | $-0.08 | ||
| Q3 24 | $-0.15 | $0.09 | ||
| Q2 24 | — | $0.10 | ||
| Q1 24 | $-0.52 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.0M | $255.7M |
| 总债务越低越好 | $10.0M | — |
| 股东权益账面价值 | $14.2M | $982.6M |
| 总资产 | $122.0M | $23.7B |
| 负债/权益比越低杠杆越低 | 0.70× | — |
8季度趋势，按日历期对齐
现金及短期投资AYTURWT
| Q4 25 | $30.0M | $255.7M | ||
| Q3 25 | $32.6M | $226.3M | ||
| Q2 25 | $31.0M | $302.0M | ||
| Q1 25 | $18.2M | $259.9M | ||
| Q4 24 | $20.4M | $245.2M | ||
| Q3 24 | $20.1M | $253.7M | ||
| Q2 24 | $20.0M | $275.6M | ||
| Q1 24 | $19.8M | $275.4M |
总债务AYTURWT
| Q4 25 | $10.0M | — | ||
| Q3 25 | $10.4M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $9.5M | — | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | $10.4M | — | ||
| Q2 24 | $10.9M | — | ||
| Q1 24 | $0 | $1.7B |
股东权益AYTURWT
| Q4 25 | $14.2M | $982.6M | ||
| Q3 25 | $23.2M | $999.0M | ||
| Q2 25 | $19.0M | $1.1B | ||
| Q1 25 | $34.9M | $1.2B | ||
| Q4 24 | $30.8M | $1.2B | ||
| Q3 24 | $29.8M | $1.2B | ||
| Q2 24 | $27.7M | $1.2B | ||
| Q1 24 | $30.8M | $1.2B |
总资产AYTURWT
| Q4 25 | $122.0M | $23.7B | ||
| Q3 25 | $125.0M | $22.6B | ||
| Q2 25 | $124.2M | $21.3B | ||
| Q1 25 | $124.2M | $19.9B | ||
| Q4 24 | $116.2M | $18.3B | ||
| Q3 24 | $115.8M | $18.4B | ||
| Q2 24 | $118.1M | $16.5B | ||
| Q1 24 | $128.9M | $15.1B |
负债/权益比AYTURWT
| Q4 25 | 0.70× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.35× | — | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.00× | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.7M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $3.7M | — |
| 自由现金流率自由现金流/营收 | 24.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AYTURWT
| Q4 25 | $3.7M | $-10.1B | ||
| Q3 25 | $-618.0K | $-2.7B | ||
| Q2 25 | $2.8M | $-2.1B | ||
| Q1 25 | $-6.5M | $-2.0B | ||
| Q4 24 | $2.9M | $-5.9B | ||
| Q3 24 | $-1.2M | $-2.1B | ||
| Q2 24 | $-788.0K | $-2.0B | ||
| Q1 24 | $-254.0K | $-954.2M |
自由现金流AYTURWT
| Q4 25 | $3.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-6.5M | — | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率AYTURWT
| Q4 25 | 24.1% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -35.4% | — | ||
| Q4 24 | 17.9% | — | ||
| Q3 24 | -8.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度AYTURWT
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.0% | — |
现金转化率AYTURWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | -0.31× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -1.62× | -120.92× | ||
| Q4 24 | 3.69× | — | ||
| Q3 24 | -0.81× | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
